DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence in Healthcare Market Analysis, by Application, by Offering, by Algorithms, by End User, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The artificial intelligence (AI) in healthcare market size is estimated to be USD 5,983.12 million in 2021 and is expected to witness a CAGR of 47.31% during the forecast period 2022-2029. The rising dataset complexity and volume of healthcare data, an increase in industry-to-industry alliances and collaborations, and advancements in processing power are some of the key drivers for the market growth. However, lack of skilled workforce and stringent rules are expected to restrain the market growth.

By Application

Based on application, the market is categorized into robot-assisted surgery, preliminary diagnosis, clinical trial participant identifier, virtual nursing assistant, fraud detection, administrative workflow assistance, dosage error reduction, and others. In 2021, the robot-assisted surgery accounted for the highest revenue share due to rise in demand for minimally invasive procedures.

By Offering

Based on offering, the market is segmented into services, hardware, and software. In 2021, the software segment accounted for the largest revenue share owing to ongoing software innovation that meets the needs of the healthcare industry.

By Algorithms

On the basis of algorithms, the market is categorized into natural language processing, deep learning, querying method, and context aware processing. In the global market, the segment accounted for the largest revenue share in 2021 owing to the rise in the usage of signal reduction, data mining, and imagery recognition.

By End User

Based on end user, the market is segmented into healthcare providers, patients, pharmaceutical & biotechnology companies, and payers. In 2021, the healthcare providers segment accounted for the largest revenue share owing to rise in the use and applications of AI systems to enhance patient outcomes and maintain EHR & patient records.

Segmentation: Artificial Intelligence (AI) in Healthcare Market Report 2021-2029

Application (Revenue, USD Million)

Robot-Assisted Surgery

Preliminary Diagnosis

Clinical Trial Participant Identifier

Virtual Nursing Assistant

Fraud Detection

Administrative Workflow Assistance

Dosage Error Reduction

Others

Offering (Revenue, USD Million)

Services

Hardware

Software

Algorithms (Revenue, USD Million)

Natural Language Processing

Deep Learning

Querying Method

Context Aware Processing

End user (Revenue, USD Million)

Healthcare Providers

Patients

Pharmaceutical & Biotechnology Companies

Payers

By Region (Revenue, USD Million)

North America

U.S

Canada

Europe

Germany

France

UK

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East & Africa

South Africa

GCC

Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Artificial Intelligence (AI) in Healthcare

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Artificial Intelligence (AI) in Healthcare Market

7. Market Analysis by Application

8. Market Analysis by Offering

9. Market Analysis by Algorithms

10. Market Analysis by End user

11. Regional Market Analysis

12. North America Artificial Intelligence (AI) in Healthcare Market

11. Europe Artificial Intelligence (AI) in Healthcare Market

12. Asia Pacific Artificial Intelligence (AI) in Healthcare Market

13. Latin America Artificial Intelligence (AI) in Healthcare Market

14. MEA Artificial Intelligence (AI) in Healthcare Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

Companies Mentioned

Recursion Pharmaceuticals (US)

Microsoft (US)

Nvidia (US)

Google (US)

Micron Technology (US)

Amazon Web Services (US)

Johnson & Johnson (US)

General Vision (US)

CloudmedX (US)

Oncora Medical (US)

Enlitic (US)

Lunit (South Korea)

Intel (US)

Qure.ai (India)

Precision Health AI (US)

Cota (US)

FDNA Inc. (US)

Siemens Healthineers (Germany)

Atomwise (US)

Koninklijke Philips (Netherlands)

Welltok (US)

Babylon Health (UK)

MDLIVE (Evernorth Group) (US)

Gauss Surgical (US)

Medtronic (US)

Qventus (US)

Desktop Genetics (US)

Cylance (US)

IBM (US)

Ginger.io (US)

General Electric Company (US)

Pillo (US)

For more information about this report visit https://www.researchandmarkets.com/r/dlsgjj